|
Published by: Global Industry Analysts
Published: Jul. 1, 2008 - 336 Pages
Table of Contents
- I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Diagnostic Devices
- Fixed PSG
- Ambulatory PSG
- Others (include Screening Devices)
- Therapeutic Devices
- CPAP
- Bi-Level PAP
- Auto PAP
- Facial Interfaces (Masks and Humidifiers)
- II. EXECUTIVE SUMMARY
- 1. Market Dynamics
- Outlook
- Diagnostic Devices
- Therapeutic Devices
- Issues & Trends
- Substantial Undiagnosed Patient Base Presents Lucrative Opportunities
- Increased Awareness of Comorbid Conditions Spurs Market Growth
- Technology Advancements Improve Patient Compliance
- Under-Penetration in CPAP Therapy Promises Significant Growth Prospects
- Industry Witnesses Consistent M&A Activity
- 2. Competition and Market Structure
- Respironics and Resmed Dominate Competitive Landscape
- Table 1: Global Market for Sleep Therapy (2004-2006): Revenues of Select Players (In US$ Million) (includes corresponding Graph/Chart)
- Table 2: Global Market for Sleep Therapy (2004-2006): Revenues of Select Players in Overseas Markets Excluding US (In US$ Million) (includes corresponding Graph/Chart)
- Table 3: Global Market for Sleep Therapy (2007E-2009P): Percentage Share of Select Players in Terms of Revenues (includes corresponding Graph/Chart)
- Table 4: Global Market for Sleep Therapy (2007E-2009P): Percentage Share of Select Players in Terms of Revenues Generated Outside the US (includes corresponding Graph/Chart)
- 3. Sleep Apnea Diagnostics and Therapeutic Devices - A Synopsis
- Significance of Sleep
- Stages of Sleep
- Sleep Disorders and Stages of Sleep
- Sleep Apnea- Introduction
- Forms of Apnea
- Central Sleep Apnea
- Physiological Effects of CSA
- Mixed Apnea
- Complex Sleep Apnea
- Obstructive Sleep Apnea - An Overview
- History
- Prevalence
- Causes of OSA
- Symptoms of OSA
- Snoring and OSA
- Risks and Complications Associated with Untreated Disorder
- Risk Groups
- Co-Morbid Conditions
- Heart Failure
- Hypertension
- Diabetes
- Fatigue
- Complications Associated with Surgery and Medications
- Financial Implications of Untreated OSA
- Pediatric OSA
- OSA Diagnosis
- Interpreting AHI
- Monitoring and Recording Technologies
- Polysomnography (PSG)
- Fixed Polysomnographs
- Ambulatory Polysomnographs
- Screening Devices
- Actigraphs
- OSA Therapies
- Positive Airway Pressure (PAP) Treatment
- Continuous Positive Airway Pressure (CPAP)
- Optional Features Available for CPAP Devices
- Bilevel Positive Airway Pressure (BiPAP)
- Auto-titrating Positive Airway Pressure (APAP)
- Masks
- Alternative Apnea Therapies
- Oral Appliances
- Surgical Procedures
- Tracheostomy
- Uvulo-palato-pharyngoplasty (UPPP)
- Mandibular Myotomy
- Laser Assisted Uvuloplasty (LAUP)
- Somnoplasty or Radio Frequency (RF) Procedure
- Pillar Palatal Implant System
- Other Surgical Therapies
- Over-the-Counter and Pharmacological Therapies
- Behavioral and Lifestyle Changes
- 4. Research Updates
- Research Finds Link Between Sleep Apnea and Heart Risks in Children
- Sleep Disorders Increase Risk for Stroke and Blood Pressure Patients
- Individuals with Sleep Apnea Face Greater Risk of Cardiac Stress During Air
- Travel
- Sleep Apnea Screening Reduces Risk of Post Operative Complications
- 5. Product Launches/Introductions
- Covidien Launches Sandman Intro CPAP Device with Heated Humidifier
- Itamar Medical Unveils Extended-Feature Sleep Diagnosis System
- Weinmann Introduces Modular Masks
- Respironics Rolls Out New Series of Masks
- Fisher & Paykel Introduces Opus™ Nasal Pillows Mask
- Fisher & Paykel Introduces SleepStyle 200 Auto Series Generators
- RespCare Introduces Hybrid™ CPAP Interface
- Teleflex Launches ConchaTherm® Neptune™ Heated Humidifier
- Teleflex Medical Unveils New Series of Bravo Mask
- ResMed Rolls Out Mirage Swift Series of Lightweight Masks
- Weinmann Launches SOMNObalance
- Weinmann Rolls Out SOMNOcheck 2 R& K
- Cardinal Introduces Respiratory System for Infants
- Respironics Releases New Headgear for OSA Patients
- Teijin Launches Compact CPAP Device
- Hoffman Launches Wearable CPAP Device
- Respironics Introduces REMstar Plus M Sleep System
- Puritan Unveils New Nasal Mask
- Teleflex Introduces Hybrid Universal Interface
- 6. Recent Industry Activity
- Royal Philips Acquires Respironics
- Cardinal Health Signs Agreement with SleepNet
- Nihon Kohden Signs New Agreement with Premier
- Tyco Healthcare is Now Covidien
- Natus Acquires XLTEK
- Breas Medical Gets Clearance from FDA to Market iSleep 20i
- ResMed Recalls 300,000 S8 Flow Generators
- Compumedics Strikes Distribution Agreement with Medigas
- Cardinal Health Takes Over VIASYS Healthcare
- VIASYS Acquires Tiara Medical
- Natus Acquires Bio-logic Systems
- 7. Focus on Select Players
- Astro-Med Inc. (US)
- Grass Technologies (US)
- Cadwell Laboratories, Inc. (US)
- Cardinal Health (US)
- Compumedics Ltd (Australia)
- Covidien Ltd (US)
- DeVilbiss Healthcare (US)
- Fisher & Paykel (New Zealand)
- Flaga Group (Iceland)
- Embla (US)
- Itamar Medical Ltd. (Israel)
- Invacare Corporation (US)
- Medical Industries America Inc. (US)
- Natus Medical Inc. (US)
- Bio-Logic (US)
- ResMed Inc. (US)
- Respironics Inc (US)
- Stellate Systems, Inc. (Canada)
- Teleflex Medical (US)
- Vital Signs Inc. (US)
- Weinmann Geräte für Medizin GmbH+CCo. KG (Germany)
- 8. Global Market Perspective
- Table 5: World Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 6: World Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 7: World 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 8: World Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 9: World Long-term Projections for Sleep Apnea Diagnostic Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 10: World 10-Year Perspective for Sleep Apnea Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 11: World Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic Devices by Product Segment - Clinical/Fixed PSG, Ambulatory PSG, and Other Devices (Screening Devices) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 12: World Long-term Projections for Sleep Apnea Diagnostic Devices by Product Segment - Clinical/Fixed PSG, Ambulatory PSG, and Other Devices (Screening Devices) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 13: World 10-Year Perspective for Sleep Apnea Diagnostic Devices by Product Segment - Percentage Breakdown of Value Sales for Clinical/Fixed PSG, Ambulatory PSG, and Other Devices (Screening Devices) Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 14: World Recent Past, Current & Future Analysis for Clinical/Fixed PSG Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 15: World Long-term Projections for Clinical/Fixed PSG Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 16: World 10-Year Perspective for Clinical/Fixed PSG Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 17: World Recent Past, Current & Future Analysis for Ambulatory PSG Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 18: World Long-term Projections for Ambulatory PSG Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 19: World 10-Year Perspective for Ambulatory PSG Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 20: World Recent Past, Current & Future Analysis for Other Diagnostic Devices (Screening Devices) by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 21: World Long-term Projections for Other Diagnostic Devices (Screening Devices) by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 22: World 10-Year Perspective for Other Diagnostic Devices (Screening Devices) by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 23: World Recent Past, Current & Future Analysis for Sleep Apnea Therapeutic Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 24: World Long-term Projections for Sleep Apnea Therapeutic Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 25: World 10-Year Perspective for Sleep Apnea Therapeutic Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 26: World Recent Past, Current & Future Analysis for Sleep Apnea Therapeutic Devices by Product Segment - CPAP, Auto CPAP, Bi-Level CPAP, and Facial Interfaces (Masks and Humidifiers) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 27: World Long-term Projections for Sleep Apnea Therapeutic Devices by Product Segment - CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 28: World 10-Year Perspective for Sleep Apnea Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers) Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 29: World Recent Past, Current & Future Analysis for CPAP Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 30: World Long-term Projections for CPAP Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 31: World 10-Year Perspective for CPAP Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 32: World Recent Past, Current & Future Analysis for Auto PAP Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 33: World Long-term Projections for Auto PAP Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 34: World 10-Year Perspective for Auto PAP Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 35: World Recent Past, Current & Future Analysis for Bi-Level PAP Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 36: World Long-term Projections for Bi-Level PAP Devices by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 37: World 10-Year Perspective for Bi-Level PAP Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 38: World Recent Past, Current & Future Analysis for Facial Interfaces (Masks and Humidifiers) by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 39: World Long-term Projections for Facial Interfaces (Masks and Humidifiers) by Geographic Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 40: World 10-Year Perspective for Facial Interfaces (Masks and Humidifiers) by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- III. MARKET
- 1. The United States
- A. Market Analysis
- Outlook
- Trends and Issues
- Sleep Apnea Population and Penetration
- Pricing Trends
- Pricing Erosion on the Rise
- Premium Products to Command Higher Prices
- Reimbursement Scenario
- CMS Includes Home Tests for Diagnosis and Treatment of Sleep Apnea
- Home Sleep Tests Pose Significant Risk for Clinical PSGs
- Reimbursement Scenario in Diagnostic and Therapy Devices
- Reimbursement Rates of CPAP Equipment (New Devices): 2008 (In US$)
- Reimbursement Rates of CPAP Equipment (Rental): 2008 (In US$)
- Average Replacement Schedules
- Competitive Landscape
- Table 41: US Market for Sleep Diagnostics Devices (2006) - Percentage Breakdown of Revenues for Covidien (formerly Tyco), Embla, Respironics, Cardinal Health/Viasys, Compumedics, Grass Technologies, Bio -Logics (Natus) and Others (includes corresponding Graph/Chart)
- Table 42: US Market for Sleep Therapeutic Devices (2006) - Breakdown of Revenues for Respironics, ResMed, Fisher & Paykel, and Covidien/Tyco in US$ Million (includes corresponding Graph/Chart)
- Table 43: US Market for Sleep Therapy (2007E - 2009E) - Percentage Breakdown of Revenues for Respironics, ResMed, Fisher & Paykel, Covidien/Tyco and Others (includes corresponding Graph/Chart)
- A Focus on the CPAP Market
- Table 44: US Market for Sleep Apnea Devices (2007-2012) - Unit Sales for Diagnostic Devices and Therapeutic Devices (includes corresponding Graph/Chart)
- Table 45: US Market for Sleep Apnea Therapeutics (2007) - Percentage Breakdown of Unit Sales of Masks by Nasal, Nasal Pillows, Full Face Masks and Mouth Masks (includes corresponding Graph/Chart)
- Distribution
- A Review of the Sleep Service Providers Market
- Greater Awareness Drives Trend Towards More Number of Beds Per Facility
- Table 46: Number of Sleep Facilities in the US: 1997-2007 (includes corresponding Graph/Chart)
- Changeover of the Sleep Lab
- Inadequate Sleep Labs - a Bottle Neck for Diagnosis of OSA
- Inadequate Sleep Labs Surge Development of Portable Sleep Monitoring
- DME Market for Sleep Apnea Devices
- Table 47: US Market for CPAP Devices (2006) - Percentage Breakdown of Value Sales by Durable Medical Equipment (DME) Suppliers for Apria Healthcare Group, Lincare Holdings Inc, National Companies and Local Operators (includes corresponding Graph/Chart)
- Product Launches
- Strategic Developments
- Select Players
- B. Market Analytics
- Table 48: US Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 49: US Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 50: US 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- 2. Japan
- A. Market Analysis
- Outlook
- Reimbursement Scenario
- Competition
- Strategic Developments
- B. Market Analytics
- Table 51: Japanese Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 52: Japanese Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 53: Japanese 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- 3. Europe
- A. Market Analysis
- Outlook
- Trends & Issues
- Ambulatory PSGs Gaining over Clinical PSGs
- Competition
- Table 54: European Sleep Diagnostics Market (2007) - Percentage Breakdown of Revenues for Embla, Respironics, Weinmann, Compumedics and Others (includes corresponding Graph/Chart)
- Product Launches
- Strategic Developments
- Select Players
- B. Market Analytics
- Table 55: European Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 56: European Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 57: European 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- Table 58: European Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 59: European Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 60: European 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- 3a. France
- A. Market Analysis
- Outlook
- Snapshots
- B. Market Analytics
- Table 61: French Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 62: French Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 63: French 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003, 2008, and 2012
- 3b. Germany
- A. Market Analysis
- Outlook
- Insurance & Reimbursement Scenario
- Reimbursement for Sleep Apnea
- Physician Support Vital for Market Penetration
- B. Market Analytics
- Table 64: German Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 65: German Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 66: German 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003, 2008, and 2012
- 3c. Italy
- Market Analysis
- Table 67: Italian Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 68: Italian Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 69: Italian 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003, 2008, and 2012
- 3d. The United Kingdom
- A. Market Analysis
- Outlook
- Snapshots
- B. Market Analytics
- Table 70: UK Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 71: UK Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 72: UK 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003, 2008, and 2012
- 3e. Spain
- Market Analysis
- Table 73: Spanish Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 74: Spanish Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 75: Spanish 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003, 2008, and 2012
- 3f. Rest of Europe
- Market Analysis
- Table 76: Rest of Europe Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 77: Rest of Europe Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 78: Rest of Europe 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003, 2008, and 2012
- 4. Rest of World
- A. Market Analysis
- Outlook
- Australia
- Significant Demand for Sleep Apnea Therapeutic Devices
- Market Shares and Players
- Table 79: Australian Sleep Apnea Therapeutic Devices Market (2007) - Percentage Breakdown of Value Sales for ResMed, Respironics, Fisher & Paykel, Covidien and Others (includes corresponding Graph/Chart)
- Compumedics Ltd - A Key Sleep Diagnostics Player
- Fisher & Paykel - A Major Sleep Therapeutics Player
- Distribution
- Table 80: Australian Sleep Apnea Therapeutic Devices Market (2007) - Percentage Breakdown of Value Sales by Major Distribution Channels (includes corresponding Graph/Chart)
- Pricing & Reimbursement
- Table 81: Australian CPAP Machines Market (2007) - Average Prices Charged by Leading Players in A$ (includes corresponding Graph/Chart)
- B. Market Analytics
- Table 82: Rest of World Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 83: Rest of World Long-term Projections for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/ Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 84: Rest of World 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
- IV. COMPETITIVE LANDSCAPE
- Total Companies Profiled: 57 (including Divisions/Subsidiaries - 116 )
- Region/Country Players
- The United States 40
- Canada 9
- Japan 3
- Europe43
- France4
- Germany 12
- The United Kingdom6
- Italy 4
- Spain 3
- Rest of Europe 14
- Asia-Pacific (Excluding Japan)15
- Middle East2
- Latin America 3
- Africa 1
AbstractThis report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in Millions of US$. The specific product segments analyzed are Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 57 companies including many key and niche players worldwide such as Astro-Med Inc., Grass Technologies, Cadwell Laboratories, Inc., Cardinal Health, Compumedics Ltd., Covidien Ltd, DeVilbiss Healthcare, Fisher & Paykel, Flaga Group, Embla, Itamar Medical Ltd., Invacare Corporation, Medical Industries America Inc., Natus Medical Inc., Bio-Logic, ResMed Inc., Respironics Inc., Stellate Systems, Inc., Teleflex Medical, Vital Signs Inc., and Weinmann Geräte für Medizin GmbH+CCo. KG. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|